Joel Palefsky, MD

Director of the ANCRE Center
Infectious Disease Specialist

Dr. Joel Palefsky is an expert in infectious diseases and cancers associated with these diseases. His expertise includes the treatment of anal dysplasia, a pre-cancerous condition that may lead to anal cancer and that is caused by the human papillomavirus (HPV). Anal dysplasia occurs in men and women and is especially common among patients infected with the human immunodeficiency virus (HIV). He also specializes in the biology and development of new treatments for HPV and Epstein-Barr virus.

Palefsky earned a medical degree at McGill University in Montreal, Canada and completed a fellowship in infectious disease at Stanford University. He is the founder and president of the International Anal Neoplasia Society and president-elect of the International Papillomavirus Society. He is a professor of medicine and laboratory medicine at UCSF.

Clinics

Anal Neoplasia Clinic, Research and Education (ANCRE) Center
1701 Divisadero, Suite 480
San Francisco CA 94115
Phone: (415) 353-7100
Fax: (415) 353- 4298

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

Academic Title

Professor

More about Joel Palefsky

Additional Languages

French

Education

McGill University 1984

Residencies

McGill University, Internal Medicine 1984

Fellowships

Stanford University, Infectious Disease 1988

Selected Research and Publications

  1. Mudini W, Palefsky JM, Hale MJ, Chirenje MZ, Makunike-Mutasa RT, Mutisi F, Murahwa A, Mario A. Human Papillomavirus Genotypes in Invasive Cervical Carcinoma in HIV Seropositive and Seronegative Women in Zimbabwe. J Acquir Immune Defic Syndr. 2018 May 16.
  2. Burger EA, Dyer MA, Sy S, Palefsky JM, De Pokomandy A, Coutlee F, Silverberg MJ, Kim JJ. Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men. J Acquir Immune Defic Syndr. 2018 May 09.
  3. Wechsler EI, Tugizov S, Herrera R, Da Costa M, Palefsky JM. E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line. J Gen Virol. 2018 Apr 06.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.